Electra Therapeutics, Inc.

ACTIVE

201 Haskins Way FL 5, 加利福尼亚州旧金山县, California, United Stateswww.electra-therapeutics.comHolding11–50 employees

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

75.0%

Phase 2

12.5%

Trial Status Distribution

Active, not recruiting

37.5%

Completed

12.5%

Not yet recruiting

12.5%

Recruiting

37.5%

Clinical Trials

Trials sponsored by this organization (8)

A Phase I Study to Evaluate ELA822

Phase 1

Recruiting

Aug 202645 participants

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Phase 1

Recruiting

interventional

Feb 202684 participants

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Phase 2

Recruiting

interventional

May 2022156 participants

Open-label Phase 1b study to evaluate safety and efficacy of ELA026 in Adults and Adolescents participants with sHLH.

Phase 1

Active, not recruiting

Apr 202224 participants

Open-label Phase 1b study to evaluate safety and efficacy of ELA026 in Adults and Adolescents participants with sHLH.

Phase 1

Active, not recruiting

Nov 202124 participants

Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers

Phase 1

Completed

interventional

Oct 202191 participants

Open-label Phase 1b study to evaluate safety and efficacy of ELA026 in Adults and Adolescents participants with sHLH.

Phase 1

Active, not recruiting

Aug 202124 participants

An Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of ELA026 in Participants with Secondary Hemophagocytic Lymphohistiocytosis (sHLH).

Not yet recruiting

interventional

8 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations